Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Maxwell

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Cancer Research|October 16, 2012
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survivalAsima Mukhopadhyay, Elizabeth R Plummer, Ahmed Elattar, et al.
Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Biomedical Physics & Engineering Express|June 26, 2024
KRASFormer: a fully vision transformer-based framework for predicting<i>KRAS</i>gene mutations in histopathological images of colorectal cancerVivek Kumar Singh, Yasmine Makhlouf, Md Mostafa Kamal Sarker, et al.
Oncotarget|December 15, 2015
Molecular classification of non-invasive breast lesions for personalised therapy and chemopreventionNiamh Buckley, David Boyle, Darragh McArt, et al.
Cancers|August 26, 2022
ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer NetworkVivek Kumar Singh, Md Mostafa Kamal Sarker, Yasmine Makhlouf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Computational and Structural Biotechnology Journal|December 26, 2023
<i>True-T</i> - Improving T-cell response quantification with holistic artificial intelligence based prediction in immunohistochemistry imagesYasmine Makhlouf, Vivek Kumar Singh, Stephanie Craig, et al.
Histopathology|August 14, 2020
Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based seriesMaurice B Loughrey, Jason McGrath, Helen G Coleman, et al.
Journal of Clinical Pathology|January 30, 2023
Technical note on the exploration of COVID-19 in autopsy materialMatthew Phillip Humphries, Victoria Bingham, Fatima Abdullah Sidi, et al.
Gynecologic Oncology|September 17, 2011
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancerJudith E Carser, Jennifer E Quinn, Caroline O Michie, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Cancer Research|October 16, 2012
Clinicopathological features of homologous recombination-deficient epithelial ovarian cancers: sensitivity to PARP inhibitors, platinum, and survivalAsima Mukhopadhyay, Elizabeth R Plummer, Ahmed Elattar, et al.
Plos One|September 25, 2014
Association between gene expression profiles and clinical outcome of pemetrexed-based treatment in patients with advanced non-squamous non-small cell lung cancer: exploratory results from a phase II studyDean A Fennell, Scott P Myrand, Tuan S Nguyen, et al.
Biomedical Physics & Engineering Express|June 26, 2024
KRASFormer: a fully vision transformer-based framework for predicting<i>KRAS</i>gene mutations in histopathological images of colorectal cancerVivek Kumar Singh, Yasmine Makhlouf, Md Mostafa Kamal Sarker, et al.
Oncotarget|December 15, 2015
Molecular classification of non-invasive breast lesions for personalised therapy and chemopreventionNiamh Buckley, David Boyle, Darragh McArt, et al.
Cancers|August 26, 2022
ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer NetworkVivek Kumar Singh, Md Mostafa Kamal Sarker, Yasmine Makhlouf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Computational and Structural Biotechnology Journal|December 26, 2023
<i>True-T</i> - Improving T-cell response quantification with holistic artificial intelligence based prediction in immunohistochemistry imagesYasmine Makhlouf, Vivek Kumar Singh, Stephanie Craig, et al.
Histopathology|August 14, 2020
Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based seriesMaurice B Loughrey, Jason McGrath, Helen G Coleman, et al.
Journal of Clinical Pathology|January 30, 2023
Technical note on the exploration of COVID-19 in autopsy materialMatthew Phillip Humphries, Victoria Bingham, Fatima Abdullah Sidi, et al.
Gynecologic Oncology|September 17, 2011
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancerJudith E Carser, Jennifer E Quinn, Caroline O Michie, et al.
Pageof 5